Effect of Acanthopanax senticosus Harms on biogenic monoamine levels in the rat brain

被引:37
作者
Fujikawa, T
Soya, H
Hibasami, H
Kawashima, H
Takeda, H
Nishibe, S
Nakashima, K
机构
[1] Mie Univ, Fac Med, Dept Biochem, Tsu, Mie 5148507, Japan
[2] Univ Tsukuba, Inst Hlth & Sports Sci, Dept Exercise Biochem, Tsukuba, Ibaraki 3058574, Japan
[3] Mie Univ, Fac Med, Dept Med Sci, Tsu, Mie 5148507, Japan
[4] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido 0600061, Japan
[5] Hlth Sci Univ Hokkaido, Dept Pharmacognosy, Ishikari, Hokkaido 0610293, Japan
关键词
Acanthopanax senticosus Harms (ASH); oral administration; dopamine; noradrenaline; striatum; hypothalamus;
D O I
10.1002/ptr.1024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The extract of the stem bark of Acanthopanax senticosus Harms (ASH) is known to have healing and protective effects on stress-induced disturbance of mental status. We have analysed whether a single or chronic (2 week) administration of ASH can affect concentrations of noradrenaline (NA), dopamine (DA) and their metabolites in the normal rat brain. A single p.o. administration of ASH elevated the NA and DA levels in the whole brain of rats in a dose-dependent manner. A single or 2 week administration of ASH (500 mg/kg) showed a marked increase in the DA level only in the striatum. However, NA levels were increased by a single dose of ASH in a wide range of brain regions such as the cortex, hypothalamus, striatum, hippocampus, substantia nigra and pons. When administered for 2 weeks no increase in NA levels was seen in these brain regions, except for an increase in the frontal cortex and anterior hypothalamus. The present results suggest that ASH may act by regulating NA and DA levels in specific brain regions related to stress response and Parkinson's disease. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:474 / 478
页数:5
相关论文
共 15 条
  • [1] ANISMAN H, 1993, ANIMAL MODELS PSYCHI, V2, P1
  • [2] NEW SUBSTANCES OF PLANT ORIGIN WHICH INCREASE NONSPECIFIC RESISTANCE
    BREKHMAN, II
    DARDYMOV, IV
    [J]. ANNUAL REVIEW OF PHARMACOLOGY, 1969, 9 : 419 - &
  • [3] DEUTCH AY, 1990, PROGR BRAIN RES, V85, P369
  • [4] Fujikawa T, 1996, BIOL PHARM BULL, V19, P1227, DOI 10.1248/bpb.19.1227
  • [5] THE NEUROBIOLOGY OF STRESS-ULCERS
    GLAVIN, GB
    MURISON, R
    OVERMIER, JB
    PARE, WP
    BAKKE, HK
    HENKE, PG
    HERNANDEZ, DE
    [J]. BRAIN RESEARCH REVIEWS, 1991, 16 (03) : 301 - 343
  • [6] REGIONAL STUDIES OF CATECHOLAMINES IN RAT BRAIN .I. DISPOSITION OF [3H]NOREPINEPHRINE [3H]DOPAMINE AND [3H]DOPA IN VARIOUS REGIONS OF BRAIN
    GLOWINSKI, J
    IVERSEN, LL
    [J]. JOURNAL OF NEUROCHEMISTRY, 1966, 13 (08) : 655 - +
  • [7] JONES MW, 1986, NEUROSCI LETT, V23, P330
  • [8] NISHIBE S, 1990, CHEM PHARM BULL, V38, P1763, DOI 10.1248/cpb.38.1763
  • [9] NISHIYAMA N, 1985, Shoyakugaku Zasshi, V39, P238
  • [10] PETKOV V, 1963, ARZNEIMITTEL-FORSCH, V13, P1078